draft: Stefano Cafarotti
{{AFC submission|d|bio|u=Cafarottistefano|ns=118|decliner=CNMall41|declinets=20250430164031|ts=20250430122836}}
{{AFC submission|d|bio|u=Cafarottistefano|ns=118|decliner=CNMall41|declinets=20250423035712|small=yes|ts=20250415200702}}
{{AFC comment|1=Per request [https://en.wikipedia.org/w/index.php?title=User_talk%3ACNMall41&diff=1288125433&oldid=1288123656 here], I took another look and unfortunately he does not meet guidelines for notability. In addition, there is a WP:REFBOMB on the draft which makes it difficult for reviewers. Notability is about the quality of the references, not the quantity. CNMall41 (talk) 16:40, 30 April 2025 (UTC)}}
{{AFC comment|1=The claim about the first surgery seems to be mainly supported by press releases or other PR. There are some studies that verify, but nothing that really talks in-depth about Cafarotti. h-index (not a solid indicator but helps) of 21. Nothing I can see that would meet WP:PROF. CNMall41 (talk) 03:57, 23 April 2025 (UTC)}}
{{AFC comment|1=In accordance with Wikipedia's Conflict of interest policy, I disclose that I have a conflict of interest regarding the subject of this article. Cafarottistefano (talk) 20:04, 15 April 2025 (UTC)}}
----
{{Short description|First Pulmonary Artery Transplant as a cancer treatment}}
{{Draft topics|stem}}
{{AfC topic|blp}}
{{Infobox scientist
| name = Stefano Cafarotti
| image = Prof. Stefano Cafarotti - Chirurgo Toracico.jpg
| caption = Prof. Stefano Cafarotti
| birth_date = {{Birth year and age|1980}}
| birth_place = Rome, Italy
| nationality = Italian
| field = Thoracic Surgery, Oncology
| work_institution = Università della Svizzera Italiana, Ente Ospedaliero Cantonale
| known_for = First main pulmonary artery transplant for thymic carcinoma
}}
Stefano Cafarotti is a professor and thoracic surgeon, head of the Thoracic Surgery Department, director of the Lung Cancer Center, and president of the board of directors of five cancer centers in southern Switzerland.{{cite web|date=2025-02-18 |language=it |title=A cantonal screening to prevent lung cancer |url=https://www.myscience.ch/news/wire/a_cantonal_screening_to_prevent_lung_cancer-2025-usi |website=myScience.ch}} {{Cite web|url=https://www.ctsnet.org/home/scafarotti |title=Prof. Stefano Cafarotti |website=CTSNet |accessdate=2025-04-30}}. He is recognized for performing the world’s first pulmonary artery trunk transplant in a patient with thymic carcinoma, significantly expanding treatment possibilities for this rare cancer {{cite journal |last1=Ambrogi |first1=Marcello Carlo |last2=Aprile |first2=Vittorio |last3=Lucchi |first3=Marco |title=Surgery for advanced thymic malignancies: how far can we push the limit? |journal=European Journal of Cardio-Thoracic Surgery |volume=63 |issue=4 |date=3 April 2023 |doi=10.1093/ejcts/ezad127 |pmid=37018144 |url=https://academic.oup.com/ejcts/article/doi/10.1093/ejcts/ezad127/7108864 |access-date=11 April 2025}}{{cite journal |last1=Cafarotti |first1=Stefano |last2=Torre |first2=Tiziano |last3=Patella |first3=Miriam |last4=Demertzis |first4=Stefanos |title=Resection of thymic carcinoma after induction therapy and reconstruction of right ventricular outflow tract with pulmonary homograft |journal=European Journal of Cardio-Thoracic Surgery |volume=63 |issue=4 |date=April 2023 |pages=ezad069 |doi=10.1093/ejcts/ezad069 |url=https://doi.org/10.1093/ejcts/ezad069 |pmid=36852845 |access-date=11 April 2025}}{{Cite web |url=https://rivercountry.newschannelnebraska.com/story/52692118/world-first-pulmonary-artery-transplant-performed-in-thymic-carcinoma-case-by-professor-stefano-cafarotti-and-team-at-ente-ospedaliero-cantonale |title=World-first pulmonary artery transplant performed in thymic carcinoma case by Professor Stefano Cafarotti and team at Ente Ospedaliero Cantonale |website=NewsChannel Nebraska |date=2023-04-28 |accessdate=2025-04-30}}{{cite web |url=https://www.bluewin.ch/it/attualita/regionali/prima-mondiale-al-cardiocentro-1251824.html |title=Prima mondiale al Cardiocentro |publisher=Bluewin |access-date=19 April 2025}}{{cite web |url=https://www.tio.ch/ticino/attualita/1588406/intervento-cardiocentro-tumore-arteria-petto |title=Intervento al Cardiocentro per un tumore all'arteria polmonare |date=8 June 2022 |publisher=Ticinonews |access-date=19 April 2025}}{{cite web |url=https://www.cardiocentro.org/it/press/un-intervento-straordinario-al-cardiocentro |title=Un intervento straordinario al Cardiocentro |publisher=Cardiocentro |access-date=19 April 2025}}{{cite web |url=https://www.benzinga.com/pressreleases/25/04/r44800812/world-first-pulmonary-artery-transplant-performed-in-thymic-carcinoma-case-by-professor-stefano-ca |title=World-First Pulmonary Artery Transplant Performed In Thymic Carcinoma Case By Professor Stefano Cafarotti |publisher=Benzinga |date=18 April 2025}}{{cite web|access-date=30 April 2025 |date=7 April 2023 |title=Intervento in prima mondiale al Cardiocentro |url=https://www.rsi.ch/info/ticino-grigioni-e-insubria/Intervento-in-prima-mondiale-al-Cardiocentro--1793300.html |website=RSI Info}}
Awards and recognition
Cafarotti was appointed an honorary faculty member of the European School of Oncology, where he also lectures in the Certificate of Advanced Studies program on thymic tumors {{cite web|author=European School of Oncology |date=2021 |language=en |title=Certificate of Advanced Studies in Lung Cancer – Second Cohort (CASLU2) – Eventi 2021 |url=https://www.eso.net/en/what-we-do/certificate+of+advanced+studies+in+lung+cancer+-+second+cohort+(caslu2)/past-events/events-2021/3-4990-0-}}.
As president of the board of directors of
the oncological centers in southern Switzerland
, he achieved the European Cancer Center certification for colorectal cancer{{cite web |url=https://www.corriereitalianita.ch/partners-eventi/lotta-tumori-colorettali-ticino-eoc |title=In Ticino, la lotta ai tumori colorettali è entrata in una nuova fase |website=Corriere dell’Italianità |date=15 February 2025}}, prostate cancer{{cite web |url=https://www.laregione.ch/cantone/ticino/1570736/svizzera-cpsi-prostata-centro-centri-certificazione-tumore-eoc |title=Tumore alla prostata, il centro dell'EOC tra le eccellenze |website=laRegione.ch |date=10 March 2022}} and lung cancer{{cite web |url=https://www.cdt.ch/news/il-centro-polmone-della-svizzera-italiana-ha-una-qualita-europea-311374 |title=Il Centro polmone della Svizzera italiana ha una qualità europea |author=Mauro Spignesi |date=19 March 2023}}
{{cite web|access-date=30 April 2025 |language=de |title=OncoMap: Zentren in der Schweiz für Darm-, Lungen- und Prostatakrebs (DKG-zertifiziert) |url=https://www.oncomap.de/centers?selectedOrgans=[Darm,Lunge,Prostata]&selectedCountries=[Schweiz]&selectedCerttypes=[DKG]&showMap=2 |website=oncomap.de}}, confirming the EUSOMA certification for breast cancer care{{cite web |url=https://www.tio.ch/ticino/attualita/1151083/centro-di-senologia-certificato-eusoma |title=Centro di senologia certificato EUSOMA |author=JC |date=19 June 2017}}.
He has also been elected to the International association for the study on lung cancer (IASCL) in the patient advocate committee
{{Cite web |url=https://www.iaslc.org/patient-advocates-committee |title=International Association for the Study of Lung Cancer - Patient Advocates Committee |website=International Association for the Study of Lung Cancer |access-date=April 30, 2025}} and in the scientific board of the brain disease foundation
References
See also
External links
- [https://www.eoc.ch/ Ente Ospedaliero Cantonale (EOC)]
- [https://www.usi.ch/ Università della Svizzera italiana (USI)]
{{Draft categories|
}}